About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3613697
Allelic
Composition
Dmpktm1Rdd/Dmpktm1Rdd
Genetic
Background
involves: 129S2/SvPas * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dmpktm1Rdd mutation (0 available); any Dmpk mutation (28 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• ultrastructurally, affected sternomastoid muscles exhibit loss of sarcomeric organization and abnormal mitochondria
• ultrastructurally, affected sternomastoid muscles exhibit focal loss of Z lines
• ultrastructurally, affected sternomastoid muscles exhibit dilation of the sarcoplasmic reticulum
• at 7-11 months, sternomastoid muscles from older (but not younger) homozygote exhibit increased variability in fiber size, with the mean fiber area ranging from 0.7 to 1.5 that of wild-type mice; no significant differences are noted in fiber type distribution or fiber total number
• in vitro, sternomastoid muscles from young (3- to 4-mo-old) homozygotes show no significant differences in isometric twitch or tetanic force, contraction or relaxation times relative to wild-type muscles
• in contrast, sternomastoid muscles from older (7- to 11-mo-old) homozygotes show a 30%-50% reduction in twitch and tetanic force generation relative to wild-type muscles
• homozygotes exhibit a progressive increase in skeletal muscle regenerative activity, as shown by a 3-4-fold increase of MyoD levels in neck, fore- and hindlimb muscles from 7- to 11-mo-old (but not younger) mutants relative to wild-type mice
• consistent with increased MyoD levels, a large proportion of fibers (1%) in sternomastoid muscles from older homozygotes express embryonic MHC vs only 0.4% of fibers in wild-type muscles, suggesting an increased incidence of muscle fiber regeneration over time
• homozygotes exhibit progressive muscle weakness in the absence of a generalized neuropathy, neuromuscular junction transmission defects, abnormal neuromuscular innervation or reduced muscle fiber membrane electrical excitability
• homozygotes display late-onset, progressive degenerative changes in skeletal muscle, including variation in fiber diameter, increased foci of degeneration/regeneration and increased fibrosis; no myotonia is ever observed

cardiovascular system
• adult homozygotes display distinct atrioventricular conduction abnormalities in the presence of normal intrinsic sinus node function
• no increased fibrosis, atrophy or altered cardiac function, chamber dimensions, wall thickness, or ventricular shortening are observed
• adult homozygotes exhibit delayed atrioventricular (A-V) conduction, manifest as first-degree (10 of 10), second-degree (5 of 17), and third-degree (2 of 17) atrioventricular block
• on ECGs, all adult homozygotes exhibit a prolonged mean P-R interval of 48 7 ms (first-degree A-V block) vs 34 5 ms in wild-type mice; in contrast, basal heart rate, P-wave duration and other ECG intervals (QRS, J-T, Q-T) remain unaffected
• a trend towards an increase in P-R intervals is noted with age, such that P-R intervals of >50 ms are not observed at 6 months, and become apparent only at 16-17 months of age
• second- and third-degree heart block occurs at a higher frequency in 16-17-month-olds and primarily in mice with a P-R interval greater than or equal to 45 ms
• no further progression of higher-grade A-V block is noted during rest, ambulation, or graded exercise testing
• left ventricle SR vesicles from 12-week-old male homozygotes show a ~2-fold decrease in phospholamban phosphorylation activity, as commonly found in acquired forms of heart failure

homeostasis/metabolism
• mutant ventricular homogenates exhibit significantly reduced Ca2+ uptake in cardiomyocyte sarcoplasmic reticulum (SR), with a 48% and 84% decrease at 200 and 20 nM free calcium concentrations, respectively, relative to wild-type
• reduced SR Ca2+ uptake is detected at 14 weeks of age i.e. prior to the first detectable signs of muscle weakness observed at 7-10 months

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
myotonic dystrophy type 1 DOID:11722 OMIM:160900
J:33714 , J:53077


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
09/22/2022
MGI 6.21
The Jackson Laboratory